2012 Financial Report

Total revenue for the fiscal year ended June 30, 2012 was $3.5 million. Generous legacy gifts and substantial contributions from annual donors as well as new donors helped make fiscal 2012 another successful year for Glaucoma Research Foundation.

Funds directed to research included the Frank Stein and Paul S. May Grants for Innovative Glaucoma Research and the Alcon Foundation, Merck, and James Wise, MD Shaffer Grants; altogether $2.8 million was committed to glaucoma research programs in fiscal 2012.

Our ongoing dedication to efficient operations ensures that 86 cents of every dollar goes directly to glaucoma research and patient education programs. We take pride in our 4-star rating from Charity Navigator, a leading independent evaluator of charitable organizations, indicating that “Glaucoma Research Foundation consistently executes its mission in a fiscally responsible way, and outperforms most other charities in America.” We meet all twenty of the Better Business Bureau’s Standards for Charity Accountability, and we are listed on GuideStar. Glaucoma Research Foundation’s financial information is available here on our website.

Thank you for your personally significant contributions to help speed the cure for this blinding eye disease and to raise awareness among those at risk.

Frederick H. Brinkmann
Treasurer

>> Download our latest Financial Report